DK2873733T4 - Vektorer til transformation af mycoplasma hyopneumoniae, transformede m. hyopneumoniae-stammer og anvendelse deraf - Google Patents

Vektorer til transformation af mycoplasma hyopneumoniae, transformede m. hyopneumoniae-stammer og anvendelse deraf Download PDF

Info

Publication number
DK2873733T4
DK2873733T4 DK13766387.8T DK13766387T DK2873733T4 DK 2873733 T4 DK2873733 T4 DK 2873733T4 DK 13766387 T DK13766387 T DK 13766387T DK 2873733 T4 DK2873733 T4 DK 2873733T4
Authority
DK
Denmark
Prior art keywords
hyopneumoniae
vectors
transformed
transformation
strains
Prior art date
Application number
DK13766387.8T
Other languages
English (en)
Other versions
DK2873733T3 (da
Inventor
Gonzalez Luis Gonzalez
Giralt Jordi Montane
Murillo Enrique Querol
Arnau Marta Sitja
Ribas Jaume Piñol
Malet Maria Camats
Original Assignee
Hipra Scient S L U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46832318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2873733(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hipra Scient S L U filed Critical Hipra Scient S L U
Publication of DK2873733T3 publication Critical patent/DK2873733T3/da
Application granted granted Critical
Publication of DK2873733T4 publication Critical patent/DK2873733T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/70—Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2820/00—Vectors comprising a special origin of replication system
    • C12N2820/55—Vectors comprising a special origin of replication system from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK13766387.8T 2012-07-10 2013-07-09 Vektorer til transformation af mycoplasma hyopneumoniae, transformede m. hyopneumoniae-stammer og anvendelse deraf DK2873733T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12382277.7A EP2684959A1 (en) 2012-07-10 2012-07-10 Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
PCT/ES2013/070492 WO2014009586A2 (es) 2012-07-10 2013-07-09 Cepas mutantes de mycoplasma hyopneumoniae

Publications (2)

Publication Number Publication Date
DK2873733T3 DK2873733T3 (da) 2019-09-30
DK2873733T4 true DK2873733T4 (da) 2023-04-03

Family

ID=46832318

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19174710.4T DK3546580T3 (da) 2012-07-10 2013-07-09 Vektorer til transformation af mycoplasma hyopneumoniae, transformerede m.hyopneumoniae-stammer og anvendelse deraf
DK13766387.8T DK2873733T4 (da) 2012-07-10 2013-07-09 Vektorer til transformation af mycoplasma hyopneumoniae, transformede m. hyopneumoniae-stammer og anvendelse deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK19174710.4T DK3546580T3 (da) 2012-07-10 2013-07-09 Vektorer til transformation af mycoplasma hyopneumoniae, transformerede m.hyopneumoniae-stammer og anvendelse deraf

Country Status (14)

Country Link
US (1) US10076561B2 (da)
EP (3) EP2684959A1 (da)
JP (2) JP6571523B2 (da)
KR (1) KR102157911B1 (da)
BR (2) BR122022000531B1 (da)
DK (2) DK3546580T3 (da)
ES (2) ES3041296T3 (da)
FR (1) FR26C1008I1 (da)
MX (1) MX362977B (da)
PL (2) PL2873733T5 (da)
PT (1) PT2873733T (da)
RU (1) RU2689671C2 (da)
WO (1) WO2014009586A2 (da)
ZA (1) ZA201500067B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2684959A1 (en) * 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
WO2014174257A2 (en) * 2013-04-22 2014-10-30 The Royal Veterinary College Methods
EP2994162B1 (en) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Vaccine for pcv2 and mycoplasma
CA3085535A1 (en) 2017-12-22 2019-06-27 Hipra Scientific, S.L.U. Intradermal combination vaccine against mycoplasma and porcine circovirus
CN110093324B (zh) * 2019-04-26 2020-02-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 基因缺失的减毒非洲猪瘟病毒及其作为疫苗的应用
RU2743595C1 (ru) * 2020-12-09 2021-02-20 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Вакцинная композиция против коронавирусной инфекции COVID-19
RU2743593C1 (ru) * 2020-12-09 2021-02-20 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Пептидные иммуногены и вакцинная композиция против коронавирусной инфекции COVID-19 с использованием пептидных иммуногенов
RU2743594C1 (ru) * 2020-12-09 2021-02-20 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Пептидные иммуногены, используемые в качестве компонентов вакцинной композиции против коронавирусной инфекции COVID-19
RU2752858C1 (ru) * 2021-02-04 2021-08-11 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Интегративный плазмидный вектор pVEAL2-S-RBD, обеспечивающий экспрессию и секрецию рекомбинантного рецепторсвязывающего домена (RBD) коронавируса SARS-CoV-2 в клетках млекопитающих, рекомбинантный штамм клеточной линии CHO-K1-RBD и рекомбинантный белок RBD SARS-CoV-2, продуцируемый указанным штаммом клеточной линии CHO-K1-RBD
WO2022186661A1 (ko) * 2021-03-04 2022-09-09 주식회사 이노백 돼지 마이코플라스마균 및 돼지 써코바이러스 감염 예방을 위한 다가 백신 조성물
KR102640730B1 (ko) * 2023-08-01 2024-02-29 주식회사 케어사이드 돼지 소모성 질병 관련 재조합 항원 제조용 신규한 벡터, 및 이를 이용한 백신 조성물
CN120366347B (zh) * 2025-03-17 2026-02-10 华南农业大学 一种质粒、副猪嗜血杆菌表面展示载体及其构建方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0715654A1 (en) 1993-08-06 1996-06-12 Biotechnology Research And Development Corporation Mycoplasma expression system
US7192594B2 (en) 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US20020187162A1 (en) 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
JP2005515162A (ja) 2001-07-02 2005-05-26 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ（Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ）を用いた単回ワクチン接種
EP1546357B1 (en) 2002-06-28 2013-08-07 Iowa State University Research Foundation, Inc. Immunogenic mycoplasma hyopneumoniae polypeptides
CA2548185A1 (en) * 2003-12-03 2005-06-16 Chugai Seiyaku Kabushiki Kaisha Expression systems using mammalian .beta.-actin promoter
JP2009528361A (ja) 2006-03-03 2009-08-06 メリアル リミテッド マイコプラズマ・ハイオニューモニエワクチン
KR100889375B1 (ko) 2007-05-18 2009-03-19 전남대학교산학협력단 이종 항원 단백질을 발현하는 약독화된 보르데텔라브론키셉티카 균주 및 그의 제조 방법, 그를 포함하는면역원성 조성물 및 그를 이용하여 발현되는 이종단백질해당 병원체의 감염증을 치료 또는 예방하는 방법
US9056909B2 (en) * 2007-11-06 2015-06-16 Zoetis Services Llc Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
KR20090061798A (ko) * 2007-12-12 2009-06-17 기아자동차주식회사 차량 시트용 시트 백의 허리 지지구조
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
KR20110128267A (ko) 2008-11-28 2011-11-29 세바 상뜨 아니말르 신규 돼지 시르코바이러스 2비 형 분리물 및 이의 용도
JP2010136627A (ja) * 2008-12-09 2010-06-24 Nippon Oil Corp 酵母にガラクトースを利用させる方法
JP5257939B2 (ja) * 2009-02-24 2013-08-07 独立行政法人農業・食品産業技術総合研究機構 豚丹毒・豚マイコプラズマ肺炎経口投与型多価ワクチン
PE20120909A1 (es) * 2009-05-19 2012-08-19 Bioproperties Pty Ltd Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma
MX2012013409A (es) 2010-05-19 2013-03-07 Bioproperties Pty Ltd Metodos relacionados a un micoplasma atenuado.
EP2684959A1 (en) * 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
WO2014174257A2 (en) 2013-04-22 2014-10-30 The Royal Veterinary College Methods

Also Published As

Publication number Publication date
ES2745720T3 (es) 2020-03-03
FR26C1008I1 (fr) 2026-04-17
ES2745720T5 (es) 2023-06-05
EP2873733B1 (en) 2019-06-26
US10076561B2 (en) 2018-09-18
PL2873733T3 (pl) 2019-12-31
US20150306200A1 (en) 2015-10-29
WO2014009586A2 (es) 2014-01-16
MX362977B (es) 2019-02-28
EP2873733B2 (en) 2023-01-18
DK2873733T3 (da) 2019-09-30
WO2014009586A8 (es) 2019-02-21
KR102157911B1 (ko) 2020-09-21
KR20150027836A (ko) 2015-03-12
BR112015000585B1 (pt) 2022-03-29
DK3546580T3 (da) 2025-12-01
RU2689671C2 (ru) 2019-05-28
JP6571523B2 (ja) 2019-09-04
MX2015000287A (es) 2015-04-10
BR112015000585A2 (pt) 2017-08-08
EP3546580B1 (en) 2025-09-03
JP6883607B2 (ja) 2021-06-09
PL3546580T3 (pl) 2026-02-02
ES3041296T3 (en) 2025-11-11
JP2019176861A (ja) 2019-10-17
EP2873733A2 (en) 2015-05-20
BR122022000531B1 (pt) 2022-06-21
RU2015104165A (ru) 2016-08-27
BR112015000585A8 (pt) 2018-01-16
PT2873733T (pt) 2019-10-14
EP3546580A1 (en) 2019-10-02
PL2873733T5 (pl) 2023-05-15
JP2015523080A (ja) 2015-08-13
ZA201500067B (en) 2016-11-30
WO2014009586A3 (es) 2014-06-12
EP2684959A1 (en) 2014-01-15

Similar Documents

Publication Publication Date Title
DK3546580T3 (da) Vektorer til transformation af mycoplasma hyopneumoniae, transformerede m.hyopneumoniae-stammer og anvendelse deraf
DK2833908T3 (da) Mycoplasma hyopneumoniae-vaccine
DK3154594T3 (da) Fap-aktiverede, terapeutiske midler og anvendelser i forbindelser dermed
DK3035936T3 (da) Visse kemiske enheder, sammensætninger og fremgangsmåder
BR302012004626S1 (pt) "configuração aplicada em leitora para dispositivo móvel."
BR112014030278A2 (pt) anticorpo, e, composição.
DK3432649T3 (da) Radionetværksknude, brugerindretning og fremgangsmåder dertil
BR112015002638A2 (pt) método para marcar informações, e aparelho
BR302012004030S1 (pt) Configuração aplicada em jaqueta.
BR302012005407S1 (pt) Configuração aplicada em banco.
BR112014032838A2 (pt) método , e aparelho.
BR302012005243S1 (pt) Configuração aplicada em torneira
DK2906608T3 (da) Polyanilin-membraner, anvendelser og fremgangsmåder dertil
BR112015018444A2 (pt) composição para prevenir infecção de mycoplasma spp., e vetor de expressão
EP2812436A4 (en) MINI-INTRONIC PLASMID VECTORS
BR112014031693A2 (pt) método, e, ferramenta.
HUE042967T2 (hu) Új, MHC-tõl független tumorasszociált antigének
DK3003298T3 (da) Antifibrogene forbindelser, fremgangsmåder og anvendelser deraf
DK2877736T3 (da) Skrue, skruedel og fremgangsmåde dertil
DK2882681T3 (da) Anordning og fremgangsmåde til overføring af fjedre
IL237541B (en) Bolaamphiphilic compounds, compositions and uses thereof
DK3030597T3 (da) Kædetermineret polymersammensætning, anvendelse deraf og fremgangsmåde til fremstilling deraf
BR112015013877A2 (pt) método, e, composição
ES1078123Y (es) Prenda electroluminiscente.
TH1401006692B (th) อุปกรณ์จัดเตรียมสารสนเทศตำแหน่ง, ระบบจัดเตรียมสารสนเทศตำแหน่ง